Abstract
COVID-19 redefined the outlook on pandemic preparedness, accelerating research toward establishing a global consortium for wastewater surveillance. Due to sample heterogeneity and low pathogen loads, microbial concentration remains a key challenge in developing low-cost, point-of-use wastewater monitoring assays. To address this challenge, we have developed a simplified version of dipstick method for RNA capture and isolation from sub-milliliter sample volumes, which simplifies RNA isolation. Given the manual steps involved in executing the dipstick method, variability is a major concern. In this work, we assessed dipstick variability through a multi-operator gage repeatability & reproducibility (gage R&R) study. We focused on detecting pepper mild mottle virus (PMMoV) and bacteriophage Phi6 in wastewater samples collected from a sewage pumping station at IIT Bombay. Our study demonstrated that the repeatability and reproducibility for the dipstick method are less than the acceptability limit of 30%, and could detect changes in PMMoV load associated with change in the population density due to summer break in our campus. Phi6 is a widely accepted surrogate for enveloped viruses such as SARS-CoV-2, and was therefore also chosen to demonstrate utility of this method for monitoring spread of infectious diseases. This work underscores the effectiveness of gage R&R in assessing and understanding the sources of variations in such assays, including operator-induced and part-to-part differences, essential for developing robust, manually-operated assays.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was partially supported by grants from Department of Science & Technology (DST), Ministry of Science & Technology, Government of India [grant no. DST/IC/IC-IMPACTS/2022/P-13] and Wadhwani Research Centre for Bioengineering (WRCB) at IIT Bombay [grant DO/2022-WRCB002-076].
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
DATA AVAILABILITY
The data that support the findings of this study are available upon reasonable request from the authors.
